In summary, these data suggest that tumor cells can induce IGF-1 secretion by osteoclasts and that osteoclast-derived IGF-1 in turn promotes the proliferation of IGF-1R-expressing nasopharyngeal carcinoma cells. This evidence concerns the gene IGF1 and nasopharyngeal carcinoma.